Metformin Induces Ultrastructural Alterations in Hepatocytes of Spontaneously Hypertensive Rats
Metformin, an oral biguanide approved for the treatment of type II diabetes is widely prescribed for other clinical conditions. Currently, metformin is being investigated as potential anti-tumor agent. However, there have been recent concerns about hepatotoxicity associated with the use of metformin...
Guardado en:
Autor principal: | |
---|---|
Lenguaje: | English |
Publicado: |
Sociedad Chilena de Anatomía
2014
|
Materias: | |
Acceso en línea: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-95022014000300016 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|